2,4-Difluoropyridine | CAS:34941-90-7

We serve 2,4-Difluoropyridine CAS:34941-90-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2,4-Difluoropyridine

Chemical Name:  2,4-Difluoropyridine
CAS.NO: 34941-90-7
Synonyms:2,4-Diffluoropyridine;
2,4-Difluoro-Pyridine;
2,4-F2C5H3N;
2,4,6-TRIMETHYL-BETA-NITROSTYRENE;
2,4-Difluoropyridin
Molecular Formula:C5H3F2N
Molecular Weight: 115.08100
 
Physical and Chemical Properties:
Density: 1.263g/cm3
Melting point: /
Boiling point:122.4ºC at 760mmHg
Flash point: 27.8ºC
Index of Refraction:1.446
 
Specification:
Appearance:  White powder
Purity:≥99.0%
 
Packing:25kg/drum
Storage:Store in a tightly closed container. Store in a cool, dry.
Application:     used in the Pharmaceutical Industrial



Contact us for information like 2,4-Difluoropyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,4-Difluoropyridin physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,4,6-TRIMETHYL-BETA-NITROSTYRENE Use and application,2,4,6-TRIMETHYL-BETA-NITROSTYRENE technical grade,usp/ep/jp grade.


Related News: The Wuhan coronavirus has brought back memories of the 2003 outbreak of the severe acute respiratory syndrome, known as SARS, which infected more than 8,000 people and killed 774.(R)-(+)-1-Butyn-3-ol manufacturer The Wuhan coronavirus has brought back memories of the 2003 outbreak of the severe acute respiratory syndrome, known as SARS, which infected more than 8,000 people and killed 774.2-Cyano-3,5-difluoropyridine supplier Among them, Zhejiang pharmaceutical companies accounted for 4 of the world’s top ten API manufacturers.2,3-Difluoro-5-methylbenzonitrile vendor An effective treatment for Alzheimer’s, which is estimated in 60%-70% of around 50 million dementia cases worldwide, could become one of the best-selling drugs globally.An effective treatment for Alzheimer’s, which is estimated in 60%-70% of around 50 million dementia cases worldwide, could become one of the best-selling drugs globally.